Dr. Gaillard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Skip Viragh Outpatient Cancer Center
201 N. Broadway
Baltimore, MD 21287Phone+1 410-955-8893- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
- Duke University School of MedicineClass of 2006
Certifications & Licensure
- MD State Medical License 2009 - 2024
- PA State Medical License 2020 - 2022
- NC State Medical License 2012 - 2017
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Start of enrollment: 2013 Feb 01
- Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA Start of enrollment: 2014 Sep 01
- A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- Transforming ovarian cancer care by targeting minimal residual disease.Amir A Jazaeri, Rachel Grisham, Anne Knisely, Stefani Spranger, Dmitriy Zamarin, R Tyler Hillman, Barrett C Lawson, Kathleen H Burns, Sanghoon Lee, Shannon N Westin, E...> ;Med. 2023 Nov 10
- 2 citationsTemozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors.Zheng-Cheng Yu, Tianhe Li, Ellen Tully, Peng Huang, Chih-Ning Chen, Philipp Oberdoerffer, Stephanie Gaillard, Ie-Ming Shih, Tian-Li Wang> ;Cancer Research. 2023 Aug 15
- 4 citationsCombination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.Stephanie L Wethington, Payal D Shah, Lainie Martin, Janos L Tanyi, Nawar Latif, Mark Morgan, Drew A Torigian, Diego Rodriguez, Simon A Smith, Emma Dean, Susan M Domch...> ;Clinical Cancer Research. 2023 Aug 1
- Join now to see all
Journal Articles
- T Cell-Inflamed Phenotype and Increased Foxp3 Expression in Infiltrating T-cells of Mismatch-Repair Deficient Endometrial CancersStephanie Gaillard, MD, Nature
Press Mentions
- Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual MeetingMay 26th, 2023
- Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer FoundationApril 26th, 2022
- 2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and ConnectionSeptember 5th, 2019
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: